Abstract: A method and device for processing a gas by forming microwave plasmas of the gas. The gas that is to be processed is set in a two or three co-axial vortex flow inside the device and exposed to a microwave field to form the plasma in the inner co-axial vortex flow, which subsequently is expelled as a plasma afterglow through an outlet of the device.

Abstract: A method and device for processing a gas by forming microwave plasmas of the gas. The gas that is to be processed is set in a two or three co-axial vortex flow inside the device and exposed to a microwave field to form the plasma in the inner co-axial vortex flow, which subsequently is expelled as a plasma afterglow through an outlet of the device.

Abstract: The present invention relates to compounds of formula I or II, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

Abstract: The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

Abstract: The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

Abstract: A compliance interface is disclosed that takes in queries from applications which may want to know if they are compliant with associated polices stored on a computing system. The interface can then interpret these queries and provide notifications and instructions to the applications. Notifications may give notice of how a policy may impact an application, and instructions may tell an application how to behave in order to stay compliant with the policies. In one aspect, the interface exposes policies set forth by parents. Via a management control panel, parents can set or alter various policies, stored in a settings store, to protect children from contact with undesirable content. The interface interprets these policies to ensure that applications, such as those provided by third party vendors, are compliant with the wishes set forth in the parents' policies.

Abstract: A compliance interface is disclosed that takes in queries from applications which may want to know if they are compliant with associated polices stored on a computing system. The interface can then interpret these queries and provide notifications and instructions to the applications. Notifications may give notice of how a policy may impact an application, and instructions may tell an application how to behave in order to stay compliant with the policies. In one aspect, the interface exposes policies set forth by parents. Via a management control panel, parents can set or alter various policies, stored in a settings store, to protect children from contact with undesirable content. The interface interprets these policies to ensure that applications, such as those provided by third party vendors, are compliant with the wishes set forth in the parents' policies.

Abstract: A compliance interface is disclosed that takes in queries from applications which may want to know if they are compliant with associated polices stored on a computing system. The interface can then interpret these queries and provide notifications and instructions to the applications. Notifications may give notice of how a policy may impact an application, and instructions may tell an application how to behave in order to stay compliant with the policies. In one aspect, the interface exposes policies set forth by parents. Via a management control panel, parents can set or alter various policies, stored in a settings store, to protect children from contact with undesirable content. The interface interprets these policies to ensure that applications, such as those provided by third party vendors, are compliant with the wishes set forth in the parents' policies.

Abstract: A polymer blend for fabricating medical products having a first 1,2 polybutadiene present from about 1% to about 99% by weight of the blend and having a first melting point temperature; and a second 1,2 polybutadiene present from about 1% to about 99% by weight of the blend and having a second melting point temperature higher than the first melting point temperature.

Abstract: The present invention provides a polymer composition having: a first component selected from homopolymers and copolymers of cyclic olefin containing polymers and bridged polycyclic hydrocarbon containing polymers, the first component being present in an amount from about 1-99% by weight of the composition; and a second component is selected from homopolymers and copolymers of a diene having from 4 to 12 carbons, the second component being present in an amount from about 99% to about 1% by weight of the composition.

Abstract: A polymer blend for fabricating medical products having a first 1,2 polybutadiene present from about 1% to about 99% by weight of the blend and having a first melting point temperature; and a second 1,2 polybutadiene present from about 1% to about 99% by weight of the blend and having a second melting point temperature higher than the first melting point temperature.

Abstract: The present invention provides a polymer composition having: a first component selected from homopolymers and copolymers of cyclic olefin containing polymers and bridged polycyclic hydrocarbon containing polymers, the first component being present in an amount from about 1-99% by weight of the composition; and a second component is selected from homopolymers and copolymers of a diene having from 4 to 12 carbons, the second component being present in an amount from about 99% to about 1% by weight of the composition.

Abstract: The invention provides benzo[b]thiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies.

Abstract: A modified quartz element having plasma and auxiliary gas ports, a upper chimney mount, a unique chimney holder and injection tube mount, and a compression plug is disclosed. The chimney holder and injection tube mount includes a specially machined groove so that a unique, double O-ring seal between the mount and the quartz element may be developed. The injection tube mount also includes a specially designed bore for receiving two O-rings so that the injector tube is supported in and sealed with the mount only through the use of resilient O-rings.